Norges Bank’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,591
| Closed | -$461K | – | 203 |
|
|
2024
Q4 | $461K | Buy |
+18,591
| New | +$461K | ﹤0.01% | 1797 |
|
|
2024
Q3 | – | Sell |
-410,799
| Closed | -$9.63M | – | 206 |
|
|
2024
Q2 | $9.63M | Buy |
410,799
+116,108
| +39% | +$2.72M | ﹤0.01% | 1406 |
|
|
2024
Q1 | $9.74M | Buy |
294,691
+281,804
| +2,187% | +$9.31M | ﹤0.01% | 1456 |
|
|
2023
Q4 | $351K | Sell |
12,887
-288,837
| -96% | -$7.86M | ﹤0.01% | 1913 |
|
|
2023
Q3 | $7.26M | Sell |
301,724
-6,910
| -2% | -$166K | ﹤0.01% | 1581 |
|
|
2023
Q2 | $9.85M | Sell |
308,634
-85,629
| -22% | -$2.73M | ﹤0.01% | 1537 |
|
|
2023
Q1 | $12.1M | Sell |
394,263
-103,748
| -21% | -$3.18M | ﹤0.01% | 1500 |
|
|
2022
Q4 | $19.5M | Buy |
498,011
+29,003
| +6% | +$1.13M | ﹤0.01% | 1283 |
|
|
2022
Q3 | $22.3M | Buy |
469,008
+19,119
| +4% | +$911K | 0.01% | 1155 |
|
|
2022
Q2 | $17.4M | Buy |
449,889
+162,653
| +57% | +$6.3M | ﹤0.01% | 1303 |
|
|
2022
Q1 | $16.5M | Buy |
287,236
+4,570
| +2% | +$262K | ﹤0.01% | 1498 |
|
|
2021
Q4 | $22.5M | Sell |
282,666
-30,887
| -10% | -$2.46M | ﹤0.01% | 1416 |
|
|
2021
Q3 | $27.3M | Buy |
313,553
+29,492
| +10% | +$2.57M | 0.01% | 1288 |
|
|
2021
Q2 | $36.6M | Sell |
284,061
-25,321
| -8% | -$3.26M | 0.01% | 1151 |
|
|
2021
Q1 | $24.8M | Buy |
+309,382
| New | +$24.8M | 0.01% | 1411 |
|
|
2020
Q3 | – | Sell |
-8,324
| Closed | -$233K | – | 2131 |
|
|
2020
Q2 | $233K | Sell |
8,324
-11,676
| -58% | -$327K | ﹤0.01% | 2069 |
|
|
2020
Q1 | $360K | Buy |
+20,000
| New | +$360K | ﹤0.01% | 2020 |
|